Antibody-derived in Vivo imaging of tau pathology

52Citations
Citations of this article
80Readers
Mendeley users who have this article in their library.

Abstract

Antibodies or their derivatives as imaging probes for pathological tau protein have great potential, but have not been well studied. In particular, smaller, single-chain-variable antibody fragments (scFv’s) are attractive for detecting tau lesions in live subjects. Here, we generated libraries of scFv’s and identified numerous phospho-tau-selective scFv’s. Peripheral injection of one of these scFv’s consistently resulted in a strong in vivo brain signal in transgenic tauopathy mice, but not in wild-type or amyloid-÷ plaque mice. The parent tau antibody provided similar results, albeit with a weaker signal intensity. The imaging signal correlated very well with colocalization of the probe with intraneuronal tau aggregates. Both were associated with markers of endosomes, autophagosomes, and lysosomes, suggesting their interaction in these degradation pathways. Such specific antibody-derived imaging probes have great potential as diagnostic markers for Alzheimer’s disease and related tauopathies.

Cite

CITATION STYLE

APA

Krishnaswamy, S., Lin, Y., Rajamohamedsait, W. J., Rajamohamedsait, H. B., Krishnamurthy, P., & Sigurdsson, E. M. (2014). Antibody-derived in Vivo imaging of tau pathology. Journal of Neuroscience, 34(50), 16835–16850. https://doi.org/10.1523/JNEUROSCI.2755-14.2014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free